Volume | 90,266 |
|
|||||
News | - | ||||||
Day High | 1.05 | Low High |
|||||
Day Low | 1.00 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Clearside Biomedical Inc | CLSD | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.02 | 1.00 | 1.05 | 1.03 | 1.01 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
350 | 90,266 | $ 1.03 | $ 93,095 | - | 0.650101 - 1.85 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:57:33 | formt | 100 | $ 1.05 | USD |
Clearside Biomedical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
63.03M | 62.41M | - | 1.33M | -32.95M | -0.53 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Clearside Biomedical News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.99 | 1.06 | 0.97 | 1.01 | 66,122 | 0.06 | 6.06% |
1 Month | 0.82 | 1.19 | 0.7564 | 1.01 | 154,486 | 0.23 | 28.05% |
3 Months | 0.8505 | 1.19 | 0.650101 | 0.8985165 | 116,986 | 0.1995 | 23.46% |
6 Months | 1.06 | 1.54 | 0.650101 | 1.03 | 120,692 | -0.01 | -0.94% |
1 Year | 1.24 | 1.85 | 0.650101 | 1.16 | 162,963 | -0.19 | -15.32% |
3 Years | 2.06 | 7.73 | 0.650101 | 3.52 | 604,816 | -1.01 | -49.03% |
5 Years | 1.48 | 7.73 | 0.56 | 2.74 | 627,069 | -0.43 | -29.05% |
Clearside Biomedical Description
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye. The product candidates of the company focus on a disease affecting the retina and aim to restore or improve visual function primarily by reducing the macular edema associated with several diseases affecting vision. |